A retrospective real-world study of nimotuzumab combined with chemotherapy for first-line treatment of advanced pancreatic cancer: A single center propensity score matched analysis

被引：0
|
作者：
Wu, Y. [1 ]
Dong, X. [2 ]
Li, E. [1 ]
Fan, Y. [2 ]
Dong, D. [3 ]
Shi, Y. [3 ]
Wang, M. [4 ]
Yang, N. [4 ]
Ou, F. [4 ]
Wang, J. [4 ]
Yang, Y. [4 ]
机构：
[1] Xi An Jiao Tong Univ, Med Coll, Affiliated Hosp 1, Med Oncol Dept, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Med Oncol, Xian, Peoples R China
[3] Xi An Jiao Tong Univ, Med Oncol, Xian, Peoples R China
[4] Xi An Jiao Tong Univ, Med Oncol, Sch Med, Xian, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1678P
引用
收藏
页码：S920 / S920
页数：1
相关论文
共 50 条
  • [1] A retrospective real-world study of nimotuzumab combined with chemotherapy for advanced pancreatic cancer
    Wu, Yinying
    Dong, Xuyuan
    Li, EnXiao
    Fan, Yangwei
    Dong, Danfeng
    Shi, Yu
    Wang, Meichen
    Yang, Nan
    Ou, Fengyun
    Wang, Jia
    Yang, Yuqian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer
    Zhan, Gouling
    Hu, Jianbing
    Da, Shijian
    Weng, Jie
    Zhou, Chuanyi
    Wen, Fang
    Liu, Songlian
    Fang, Fang
    Shen, Erdong
    Zhou, Qiang
    Luo, Pan
    Xu, Min
    Zhan, Dahe
    Su, Yuqi
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [3] First-line chemotherapy with gemcitabine in advanced pancreatic cancer: a retrospective single-center analysis
    Magalhaes, H.
    Cassiano Neves, M.
    Fontes e Sousa, M.
    Machado, M.
    Marques, D.
    Faustino, C.
    Sousa, N.
    Ferreira, P.
    Raimundo, A.
    Fragoso, M.
    Luis, M.
    Sales, C.
    ANNALS OF ONCOLOGY, 2015, 26
  • [4] First-line chemotherapy regimens associated with survival in advanced pancreatic cancer: A Mexican single-center, real-world study.
    Herrera, Marytere
    Diaz, Andrea Maliachi
    Diaz, Consuelo
    Michaus, Veronica Salais
    Ruiz, Erika
    Garcia, Sebastian
    Adame, Sayako Miyagui
    Ruiz, German Calderillo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 683 - 683
  • [5] First-line systemic treatment outcomes in a real-world advanced pancreatic cancer cohort
    Tafenzi, H. A.
    Takniouine, Y. Ait
    Haag, E. K.
    Abdillahi, B. D.
    Choulli, F.
    Baladi, A.
    Essadi, I.
    Belbaraka, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S153 - S153
  • [6] FOLFOXIRI versus FOLFIRINOX in first-line chemotherapy in patients with advanced pancreatic cancer: A propensity score analysis
    Vienot, A.
    Chevalier, H.
    Bolognini, C.
    Gherga, E.
    Meurisse, A.
    Vernerey, D.
    Borg, C.
    Turpin, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [7] A Multi-center Retrospective Study on First-line Chemotherapy for Advanced Pancreatic Cancer in China
    Cui, H.
    Deng, G.
    Yuan, J.
    Lou, C.
    Zhang, W.
    Zhou, A.
    Zhang, Y.
    Zhou, J.
    Dai, G.
    PANCREAS, 2020, 49 (10) : 1404 - 1404
  • [8] Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
    Wang, Fangzheng
    Sun, Quanquan
    Jiang, Chuner
    Liu, Tongxin
    Rihito, Aizawa
    Masoto, Sakamoto
    Wang, Yuezhen
    Fu, Zhenfu
    Chen, Ming
    JOURNAL OF CANCER, 2018, 9 (03): : 594 - 603
  • [9] A retrospective real-world study for nimotuzumab plus postoperative adjuvant chemotherapy for resectable pancreatic cancer
    Zou, S.
    Zhan, Q.
    Wen, C.
    Li, F.
    Zhao, S.
    Jiang, L.
    Chen, H.
    Deng, X.
    Shen, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S921 - S921
  • [10] A Chinese Retrospective Multicenter Study of First-Line Chemotherapy for Advanced Pancreatic Cancer
    Cui, Hanzhi
    Guan, Jingzhi
    Deng, Guochao
    Yuan, Jiajia
    Lou, Changjie
    Zhang, Wen
    Zhou, Aiping
    Zhang, Yanqiao
    Zhou, Jun
    Dai, Guanghai
    MEDICAL SCIENCE MONITOR, 2020, 26
12345